Orchestra Biomed Holdings, Inc. balance sheet

At the end of fiscal 2025, Orchestra Biomed Holdings, Inc. had total assets of $115m, total liabilities of $51.5m and shareholders' equity of $53.6m. It held $34.7m in cash against $15.0m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Orchestra Biomed Holdings, Inc.: balance sheet, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	20	31	22	35	20
Receivables	0	0	0	0	0
Inventory	0	0	0	0	0
Total current assets	85	89	69	108	111
Total assets	96	95	76	115	116
Accounts payable	4	3	5	6	6
Deferred revenue (current)	6	3	4	—	—
Total current liabilities	19	11	16	17	13
Long-term debt	—	—	15	15	20
Total debt	0	10	15	15	20
Total liabilities	43	27	43	51	86
Shareholders' equity	53	68	33	54	19
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	10	10
Shares outstanding	—	36m	38m	57m	60m

US$ millions unless shown otherwise. Fiscal quarters.

Orchestra Biomed Holdings, Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	0	0	0	0	0	0	0	0
Inventory	0	0	0	0	0	0	0	0
Total current assets	69	69	52	36	98	108	96	111
Total assets	75	76	59	43	105	115	101	116
Accounts payable	5	5	6	5	8	6	6	6
Deferred revenue (current)	4	4	4	4	5	—	—	—
Total current liabilities	16	16	15	17	21	17	14	13
Long-term debt	—	15	15	15	15	15	15	20
Total debt	—	15	15	15	15	15	15	20
Total liabilities	29	43	42	43	61	51	50	86
Shareholders' equity	46	33	17	0	44	54	41	19
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	—	—	10	10	10
Shares outstanding	38m	38m	38m	39m	56m	57m	59m	60m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: OBIO vs POCI OBIO vs RVP OBIO vs STXS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Orchestra Biomed Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Orchestra Biomed Holdings, Inc.